What really happens to your body when you stop weight loss medications like OzemPIC
Discourse patients may find medications to help them lose weight a recovery in weight gain after stopping medical prescription BMC Medicine. The study, which analyzes data for patients who receive weight loss medications across 11 random experiments, indicates that although the amount of weight that regains varies depending on the specified drug, there is a wide direction in restoring the weight associated after the end of the drug.
Six anti-population drugs (AOMS) have been approved by the US Food and Drug Administration for use in weight loss, including Orlistat, PhenterMine-Topiramate and Semaglutide. Glp-1-a remedy for diabetes-is also increasingly prescribed to help patients lose weight. However, recent studies have suggested that prescribed patients may restore weight in the months that followed the end of these medications.
Xiaoling Cai and Linong Ji and his colleagues conducted a masculine analysis of 11 studies from all over the world looking to change weight in patients after stopping Aoms. In general, the authors analyzed data from 1574 participants in the treatment groups and 893 in control groups. Weight change was measured by changes in body weight and body mass index after stopping the drug. Among 11 studies included in metaphysical analysis: six focused on GLP-1 receptors; One focus on GLP-1 and GLP Dual RAS; One study focused on Orlistat; Two studies on Vinteremin Topuramet; And one study on Naltexone-BuprioPion.
Authors control various contributing factors, including the type of drug, the presence of diabetes, the presence or lack of lifestyle changes such as diet or exercise. Their analysis found that AOMS was associated with a significant weight loss while using it, followed by weight restoring weight from eight weeks after Aom stops, with weight restoration after that for 20 weeks on average. Various weight varies with follow -up, as the study participants suffer from significant weight in eight, 12 and 20 weeks after Aom stops. The amount of weight that has been restored depends on several factors, including the type of medications that the participants take and the consistency of their lifestyle. For example, participants who have completed a 36-week treatment of Tirzepatide, the GLP-1 RA commercially available, regained nearly half of the previously lost weight after switching to the imaginary medicine.
The authors note that the twin analysis did not include studies on lifestyle interventions and obesity surgery, which reduces the degree that can compare different weight loss methods in the context of the study. They also notice that the weight restoration has been reported with other ways to lose weight, such as infectious waste and vertical stomach beautification.
(Tagstotranslate) Diet and weight loss; Diabetes; obesity; Pharmacy is a physical fitness; Pharmaceutical preparations for personal medicine; Alternative medicine














Post Comment